Most trusted source for Tendering Opportunities and Business Intelligence since 2002
Country - United States
Summary - Notice Of Intent To Sole Source - Commercial Packaging And Validation For The Arakoda (Tafenoquine) Anti-Malarial Drug
Deadline - login to view
GT reference number - 81331403
Product classification - Business services: law, marketing, consulting, recruitment, printing and security
Address - United States
Contact details - 565656565
Tender notice no. - 76454545
GT Ref Id - 81331403
Document Type - Tender Notices
Description - Notice of Intent to Sole Source The United States Army Medical Research Acquisition Activity (USAMRAA), on behalf of the United States Army Medical Materiel Development Activity (USAMMDA) is issuing this notice of intent to award a new contract on a sole source basis. This is not a request for proposals. This notice does not represent a commitment by the Government to pay for costs incurred from the preparation and/or submission of data in response to this notice. The Government intends to award a sole source contract, in accordance with FAR 6.302-1(a)(2), to 60 Degrees Pharmaceuticals, Incorporated (60P), 1025 Connecticut Ave, STE 1000, Washington, D.C. 20036-5417. This is a new contract fo
Gt Ref Id - 81331403
Deadline - May 10, 2024
View more tenders for
Pharmaceuticals Tenders Business services: law, market Tenders United States TendersSimilar Tenders :
Why Us
3,00,000 +
Users
190 +
Countries Covered
5,00,000 +
Agencies Tracked
50,000 +
Notices Daily
90 Million +
Database